Unbalanced risk-benefit analysis of ADHD drugs - Authors' reply

Lancet Psychiatry. 2018 Nov;5(11):871-873. doi: 10.1016/S2215-0366(18)30396-1. Epub 2018 Oct 26.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Adolescent
  • Adult
  • Attention Deficit Disorder with Hyperactivity*
  • Child
  • Humans
  • Network Meta-Analysis
  • Risk